GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (WBO:DXCM) » Definitions » YoY Rev. per Sh. Growth

DexCom (WBO:DXCM) YoY Rev. per Sh. Growth : 2.01% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is DexCom YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. DexCom's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was 2.01%.

DexCom's Revenue per Share for the three months ended in Sep. 2024 was €2.18.

DexCom YoY Rev. per Sh. Growth Historical Data

The historical data trend for DexCom's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom YoY Rev. per Sh. Growth Chart

DexCom Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.00 12.87 24.43 27.15 21.49

DexCom Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.32 25.91 22.84 20.06 2.01

DexCom YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

DexCom's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(7.806-6.425)/ | 6.425 |
=21.49 %

DexCom's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=(Revenue per Share (Q: Sep. 2024 )-Revenue per Share (Q: Sep. 2023 )) / | Revenue per Share (Q: Sep. 2023 )) |
=(2.184-2.141)/ | 2.141 |
=2.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexCom YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of DexCom's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

DexCom Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (WBO:DXCM) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
ZBH STE PODD EW GMED PEN BIO MASI BRKR GKOS ABT SYK BSX MDT XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271 ASX:COH
Traded in Other Exchanges
DXCM:USA DXCM:Mexico 0A4M:UK DC4:Germany DC4:Germany DC4:Germany DC4:Germany D1EX34:Brazil
Address
6340 Sequence Drive, San Diego, CA, USA, 92121
Website
https://www.dexcom.com
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.